Why the study?
Do pharmacologic neuroprotective agents reduce adverse cerebral consequences in patients undergoing cardiac surgery?
Population
Patients undergoing cardiac surgery
Design
Review
Authors
Loading...
No approved neuroprotective agents for cardiac surgery; leaves open whether targeted trials can identify effective options.
Do pharmacologic neuroprotective agents reduce adverse cerebral consequences in patients undergoing cardiac surgery?
Despite extensive research into various pharmacologic agents, no drug is currently approved or definitively proven to provide neuroprotection during cardiac surgery.
Hilary P. Grocott (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: